Cargando…

Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants

OBJECTIVES: The objective of this pharmacometric (PMX) study was to (i) characterize population pharmacokinetics (PPK) and exposure-pain response associations following intranasal (0.1 mg/kg) or intravenous (IV, 0.05 mg/kg) administration of nalbuphine, with the goal to (ii) evaluate strategies for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfiffner, Miriam, Berger-Olah, Eva, Vonbach, Priska, Pfister, Marc, Gotta, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926166/ https://www.ncbi.nlm.nih.gov/pubmed/35311056 http://dx.doi.org/10.3389/fped.2022.837492

Ejemplares similares

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Intranasal Dexmedetomidine With Intravenous Midazolam: A Safe and Effective Alternative in the Paediatric MRI Sedation
por: KG, Kavya, et al.
Publicado: (2023)

Respiratory and hemodynamic effects of intravenous nalbuphin in anesthetized rats
por: Hauffe, T, et al.
Publicado: (2015)

Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants
por: van Donge, Tamara, et al.
Publicado: (2018)

Clinically practical pharmacometrics computer model to evaluate and personalize pharmacotherapy in pediatric rare diseases: application to Graves' disease
por: Steffens, Britta, et al.
Publicado: (2023)

Effect of nalbuphine on rocuronium injection pain
por: Huang, Wenfang, et al.
Publicado: (2021)

Optimizing moxidectin dosing for Strongyloides stercoralis infections: Insights from pharmacometric modeling
por: Hofmann, Daniela, et al.
Publicado: (2021)

Efficacy and Safety of Intravenous Ketorolac versus Nalbuphine in Relieving Postoperative Pain after Tonsillectomy in Children
por: Eladi, Islam Adel, et al.
Publicado: (2019)

Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial
por: Zheng, Xiaosu, et al.
Publicado: (2023)

The application of nalbuphine in patient-controlled intravenous analgesia for patients undergoing subtotal gastrectomy
por: Yang, Li, et al.
Publicado: (2018)

Metaheuristics for pharmacometrics
por: Kim, Seongho, et al.
Publicado: (2021)

Intravenous Propofol Allows Fast Intubation in Neonates and Young Infants Undergoing Major Surgery
por: Sgrò, Stefania, et al.
Publicado: (2019)

Comparison of preadministered and coadministered lidocaine for treating pain and distress associated with intranasal midazolam administration in children: A randomized clinical trial
por: O'Connell, Nicole C., et al.
Publicado: (2020)

Evaluation of machine learning methods for covariate data imputation in pharmacometrics
por: Bräm, Dominic Stefan, et al.
Publicado: (2022)

Description of a clinical decision support tool with integrated dose calculator for paediatrics
por: Higi, Lukas, et al.
Publicado: (2021)

Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis
por: Koch, Gilbert, et al.
Publicado: (2020)

Comparison Between Intravenous Nalbuphine and Lidocaine in Reducing Propofol-Induced Injection Pain During Gastroscopy: A Randomized Controlled Trial
por: Wang, Jiang, et al.
Publicado: (2020)

Pharmacometrics: Focus on the Patient
por: Dumitrescu, T Pene, et al.
Publicado: (2015)

Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Pharmacometrics and/or Systems Pharmacology
por: van der Graaf, Piet H.
Publicado: (2019)

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics
por: van Hasselt, J G Coen, et al.
Publicado: (2012)

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

Safety of nurse-directed triage intranasal fentanyl protocol for acute pain management in a European pediatric emergency department: A retrospective observational analysis
por: Romano, F., et al.
Publicado: (2023)

Surveillance of Acute SARS-CoV-2 Infections in School Children and Point-Prevalence During a Time of High Community Transmission in Switzerland
por: Kriemler, Susi, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants
por: Kohlmaier, Benno, et al.
Publicado: (2021)

Sedative, analgesic, behavioral and clinical effects of intravenous nalbuphine-xylazine combination in camels (Camelus dromedarius)
por: Khalil, Ahmed H., et al.
Publicado: (2019)

Influences of Gender on Intravenous Nalbuphine Actions After Major Abdominal Surgery: A Multicenter Study
por: Ayad, Amany E., et al.
Publicado: (2021)

Randomized Double-Blinded Comparative Study of Intravenous Nalbuphine and Tramadol for the Treatment of Postspinal Anesthesia Shivering
por: Nirala, Deepak Kumar, et al.
Publicado: (2020)

Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
por: Baumann, Philipp, et al.
Publicado: (2017)

Preemptive Intravenous Nalbuphine for the Treatment of Post-Operative Visceral Pain: A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
por: Liu, Xiaofen, et al.
Publicado: (2021)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
por: Wu, Shu, et al.
Publicado: (2019)

Impact of a clinical decision support system on paediatric drug dose prescribing: a randomised within-subject simulation trial
por: Higi, Lukas, et al.
Publicado: (2023)

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Role of pharmacometrics and systems pharmacology in facilitating efficient dose optimization in oncology
por: Jayachandran, Priya, et al.
Publicado: (2023)

CPT: Pharmacometrics and Systems Pharmacology
por: van der Graaf, Piet H
Publicado: (2012)

Opinion: The Pharmacometrics of Infectious Disease
por: Davies, G R, et al.
Publicado: (2013)

Pharmacometric Characterization of Dabigatran Hemodialysis
por: Liesenfeld, Karl-Heinz, et al.
Publicado: (2013)

CPT: Pharmacometrics & Systems Pharmacology
Publicado: (2013)

CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7h9k7mbgeqr4ed0ffmcs1b80uh